Ebola and Hantavirus Protocols in Manitoba 

Though risk to Manitobans remains low, Public Health is providing new guidance to health care providers about two current international outbreaks. 

Ebola

Health care providers should suspect Ebola in individuals with: 

• A travel history to an Ebola disease affected area within 21 days of symptom onset (currently the Democratic Republic of Congo and Uganda) AND 

• A new-onset fever ≥ 38.0 degrees Celsius, or other new, Ebola-compatible symptoms. 

Hantavirus

Promptly contact a Medical Officer of Health (MOH) at 204−788−8666 for further guidance if you identify an individual with suspected Andes hantavirus infection with: 

• Clinical symptoms consistent with hantavirus pulmonary syndrome, AND 
• A potential epidemiologic link to the Andes virus outbreak through recent travel or exposure to rodents in South America. 

Read the memo to health care providers.

Exception Drug Status Updates 

This month’s Manitoba Drug Benefits and Manitoba Drug Interchangeability Formulary Amendments Bulletin is out and includes updates on: 

• Exception Drug Status Additions 
• New Interchangeable Categories & Products 
• Discontinued Products

These amendments take effect Monday, June 1.

New HIV Resource 

The Manitoba HIV Program has released a new infographic from Manitoba HIV Program aiming to help physicians and other health care providers diagnose and treat HIV. 

• As we reported this month, Manitoba has declared a public health emergency in response to a sharp rise in HIV cases with rates now among the highest in Canada. 
• The increase reflects broader challenges tied to substance use, housing instability, mental health, and inequitable access to care. 

View the guidelines here.

Clinical Practice Changes 

Here are this week’s Clinical Practice Changes from Shared Health. 

• Provincial bone mineral density test requisition — effective May 21 
• Request for Pre Transfusion Testing and Blood Components Requisition Update and associated form – effective June 15* 

*This communication does NOT apply to sites within Winnipeg, Portage District Hospital, and Bethesda (Steinbach) Regional Health Center at this time as Canadian Blood Services (CBS) will continue to provide pre-transfusion testing services at this time.

Health Product InfoWatch: May 2026 

Canada Health is out with its monthly recap of health product safety information. It includes: 

• Health product advisories 
• Type 1 drug recalls 
• Summaries of completed safety reviews 

View the advisory.